Sorry, you need to enable JavaScript to visit this website.

    Pfizer Names Amy W. Schulman as Senior Vice President and General Counsel

    (BUSINESS WIRE)--Pfizer Inc today named Amy W. Schulman as Senior Vice President and General Counsel, effective June 23. In her new role, Ms. Schulman will be responsible for leading Pfizers legal division. She will serve on the companys Executive Leadership Team (ELT) and will report directly to Chairman and Chief Executive Officer Jeffrey B. Kindler.

    Ms. Schulman joins Pfizer from DLA Piper, where she was a partner and co-leader of the firms mass tort/class action practice. In that capacity, Ms. Schulman handled some of the most complicated legal, scientific and regulatory issues facing the worlds most respected companies, including Pfizer. While at DLA Piper, Ms. Schulman served as lead national counsel in the multi-district litigation involving Bextra and Celebrex.

    Amy is a highly regarded and effective legal strategist who has vast experience leading large teams of attorneys, Mr. Kindler said. We are fortunate to have someone of her caliber join Pfizer. We know first hand the outstanding qualities that Amy brings to us. Her knowledge of the legal, business and regulatory challenges facing the pharmaceutical industry and her experience tackling large, complex cases make her uniquely qualified to lead Pfizers legal team.

    Ms. Schulman, 47, joined DLA Piper in 1997 and served on the firms Global Board and U.S. Executive and Policy Committees. She also spearheaded a number of the firms strategic initiatives, most notably in the areas of client service, diversity and inclusiveness, and mentoring.

    I am honored to join Pfizer, a company with a long and impressive history of pharmaceutical innovation, Ms. Schulman said. I am excited about joining the terrific and talented group of colleagues in the Legal Division and look forward to working together with the Pfizer leadership team that Jeff has brought together.

    Ms. Schulman has been recognized repeatedly for her commitment to clients and her skill as a legal advocate. The American Lawyer named her a Top Commercial Litigator in 2006. Chambers USA:Americas Leading Lawyers for Business called Ms. Schulman one of the best strategic lawyers around. In 2004, The American Lawyer recognized her as one of the 45 legal superstars under the age of 45.

    Ms. Schulman is a Phi Beta Kappa graduate from Wesleyan University in 1982 where she double majored with honors in philosophy and English. She earned her J.D. from Yale University Law School in 1989.

    Ms. Schulman serves on the board of directors of the Brooklyn Academy of Music and Equal Justice Works, and is on the steering committee of DRI Drug and Medical Device.

    About Pfizer Inc

    Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, approximately 85,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.


    Pfizer Inc
    Chris Loder, 212-733-7897
    Suzanne Harnett, 212-733-8009


    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 


    Sign Up Now